Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thiazide diuretics in renal hypercalciuria.

A Aroldi, G Graziani, G Mioni

    Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association
    |January 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Idiopathic erythrocytosis: a germline disease?

    Clinical and experimental medicine·2024
    Same author

    Pressure tuning of light-induced superconductivity in K<sub>3</sub>C<sub>60</sub>.

    Nature physics·2018
    Same author

    Possible light-induced superconductivity in K3C60 at high temperature.

    Nature·2016
    Same author

    Risk factors associated to kidney stones in primary hyperparathyroidism.

    Journal of endocrinological investigation·2005
    Same author

    Natural history of hepatitis C virus infection in adult renal graft recipients.

    Transplantation proceedings·2005
    Same author

    [Hepatitis C virus and renal transplantation].

    Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2004

    Hydrochlorothiazide and amiloride treatment helped most renal hypercalciuric patients. However, developing hypercalcaemia during treatment may identify non-suppressible hyperparathyroidism, aiding diagnosis.

    Area of Science:

    • Nephrology
    • Endocrinology
    • Pharmacology

    Background:

    • Renal hypercalciuria is a risk factor for kidney stone formation.
    • Normocalcaemic hyperparathyroidism can be challenging to diagnose.
    • Hydrochlorothiazide and amiloride are commonly used to manage hypercalciuria.

    Purpose of the Study:

    • To evaluate the efficacy of hydrochlorothiazide and amiloride in reducing stone formation and parathyroid hyperactivity.
    • To investigate the diagnostic utility of hydrochlorothiazide/amiloride-induced hypercalcaemia in identifying specific patient subgroups.

    Main Methods:

    • A cohort of 46 renal hypercalciuric normocalcaemic patients received hydrochlorothiazide (50mg/day) and amiloride (5 mg/day).
    • Treatment outcomes included changes in urinary calcium excretion and parathyroid hormone levels.

    Related Experiment Videos

  • Patients who developed hypercalcaemia were further assessed, with some undergoing parathyroidectomy.

    • Main Results:

    • 41 out of 46 patients showed reduced hypercalciuria and suppressed parathyroid activity.
    • Five patients did not exhibit parathyroid suppression and developed hypercalcaemia.
    • Parathyroidectomy in four of these five patients normalized biochemical markers of hyperparathyroidism.

    Conclusions:

    • Hydrochlorothiazide and amiloride are effective in managing hypercalciuria and parathyroid hyperactivity in most patients.
    • The development of hypercalcaemia during this treatment can serve as a diagnostic marker for pharmacologically resistant hyperparathyroidism.
    • This finding aids in identifying patients with non-suppressible normocalcaemic hyperparathyroidism.